Year: 2012
Type: article
Abstract: We thank Professors Carvalho and Landau for their kind comments and interest in our paper [1]. We are pleased that our publication raised a number of discussion points and we welcome the opportunity to comment. Firstly, they suggest that the combined-spinal epidural (CSE) group received less initial analgesia as evidenced by a shorter duration of effective analgesia, lower maximum sensory blocks and a trend towards higher pain scores before the second dosing, compared with epidural. The first doses we used were approximately twice the EC50 of epidural bupivacaine and 3.6 times the ED50 of intrathecal bupivacaine estimated in previous minimum local analgesic concentration (MLAC) studies [2, 3]. Through the derivation of point estimates for EC95 and ED95, in proportional terms the CSE group received the greater dose at ED50/EC50 (by a factor of 1.8) and to a lesser extent at ED95/EC95 (by a factor of 1.35). We feel that the greater MLAC in the CSE group could not be explained simply by the CSE group’s receiving less analgesia. We accept that although it may be possible to design a study with pharmacodynamic equipotency, pharmacokinetic equipotency is a different matter. Unfortunately we were not able, and it is not pragmatic, to control for both. Carvalho and Landau are correct that the differences must somehow be related to residual analgesia, but the actual washout duration was determined by the individual patients. Our observation was that the epidural group required rescue analgesia later in labour with lower concentrations. We hope that the authors will accept that the regimens for the initiation of blockade are reasonable, given that the frequency of ineffective analgesia after the first injection in the CSE group did not differ significantly from that in the epidural group. Although the block heights were lower in the CSE group (median T8 compared with T6 in the epidural group), both groups had adequate levels of block to achieve analgesia for the first stage of labour. If accepted, one must accept the observation that the epidural group ‘survived’ longer to rescue and required less additional local anaesthetic. In our study, therefore, epidural dosing was preferable in terms of both efficacy and subsequent analgesic requirements. We agree that the methodology is not generalisable to routine clinical practice. As the authors suggest, the routine use of an epidural infusion could have confounded the subsequent MLAC determinations. In a post-hoc analysis, we entered the three possible confounding variables suggested by the authors as covariates in a mixed linear models analysis, to assess any effect on the potency ratio. As shown in Table 1, there is little effect of the covariates, singularly or combined, on the estimates reported previously. Whilst we agree that the pharmacokinetic issues confound a clear interpretation, it is clear from this study that epidural loading seems to affect favourably the subsequent epidural analgesic requirements. We, like the authors, await further investigations to take this forward.
Source: Anaesthesia
Authors: S Armstrong, R Fernando, M. Columb
Language: English
Subfield: Anesthesiology and Pain Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W4236841398
